Abivertinib
Abivertinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target tyrosine-protein kinase JAK3, epidermal growth factor receptor, and tyrosine-protein kinase BTK.
Trade Name | |
---|---|
Common Name | Abivertinib |
Indication | |
Drug Class | Tyrosine kinase inhibitors: epidermal growth factor receptor (EGFR) inhibitors |